Vaxcyte Inc
(FRA:5VA)
€
67
1 (1.52%)
Market Cap: 7.32 Bil
Enterprise Value: 5.96 Bil
PE Ratio: 0
PB Ratio: 3.96
GF Score: 42/100 Vaxcyte Inc (FRA:5VA) Transcripts
- Q4 2023 Vaxcyte Inc Earnings Call TranscriptFeb 27, 2024€75.5 (+7.09%)Earnings
- Vaxcyte Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Vaxcyte Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Vaxcyte Inc VAX-24 Phase 2 65+ Adult Study Results Call TranscriptApr 17, 2023
- Q4 2022 Vaxcyte Inc Earnings Call TranscriptFeb 27, 2023€39.2 (-2.49%)Earnings
- Vaxcyte Inc VAX-24 Phase 1/2 Proof-of-Concept Study Topline Data Call TranscriptOct 24, 2022
- Vaxcyte Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Vaxcyte Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
- Q4 2021 Vaxcyte Inc Earnings Call TranscriptFeb 28, 2022€19.9 (+0.51%)Earnings
- Vaxcyte Inc at Guggenheim Vaccine and Infectious Disease Conference (Virtual) TranscriptOct 05, 2021
- Vaxcyte Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q4 2020 Vaxcyte Inc Earnings Call TranscriptMar 29, 2021Earnings
- 1